课题基金 / 基金详情

项目摘要

项目成果

ALEXANDER KHORUTS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Regulatory CD25+CD4 T cells are important mediators of immunologic tolerance and are likely to become a therapeutic target. However, their mechanisms in vivo remain largely unknown, and are the main focus of this proposal. The summary of the preliminary work described here shows that 1) we are able to purify in numbers sufficient for the proposed experiments antigen-specific regulatory CD25+CD4 T_;_.!!._ from wild-type TCR Tg mice and antigen-specific regulatory CD25+CD4 T cells expressing a single known TCR; 2) we have established two complementary in vivo systems to measure suppressive effects of CD25+CD4 T cells on responder T cells in non-lymphopenic animals; 3) we are able to simultaneously visualize the behavior and cellular interactions of antigen-specific CD25+CD4 T cells, antigen-specific responder T cells, and antigen-presenting dendritic cells; 4) CD25+CD4 T cells reduce the size of the T cell population responding to antigen and inhibit production of effector Thl and Th2 cytokines; and 5) CD25+CD4 T cells inhibit homeostatic proliferation of naive T cells in lymphopenic mice. The laboratory is now exceptionally poised to pursue the two specific aims in the proposal. In the first aim we will define the cellular mechanisms of by which CD25+CD4 T cells inhibit the antigen-specific T cell responses within the secondary lymphoid tissues. We will determine the fates of the dendritic cells presenting the antigen as well the antigen-specific CD25+CD4 T cells and responder T cells. In the second aim we will determine how CD25+CD4 T cells shape the development of the T cell compartment during immune reconstitution by homeostatic proliferation. In particular, we will test how CD25+CD4 T cells may regulate potentially auto-aggressive T cell clones under conditions of lymphopenia. Although cellular mechanisms constitute the main focus of this proposal, the experimental systems described are robust and are ideally suited for testing roles of specific molecules in CD25+CD4 T cell-mediated immune regulation.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.imlet.2004.10.022
发表时间: 2005-04-15
期刊: Immunology letters
影响因子: 4.4
作者: [Khoruts A, Fraser JM]
通讯作者: Fraser JM
A model of suppression of the antigen-specific CD4 T cell response by regulatory CD25+CD4 T cells in vivo.
体内调节性 CD25 CD4 T 细胞抑制抗原特异性 CD4 T 细胞反应的模型。
DOI: 10.1093/intimm/dxh213
发表时间: 2005
期刊: International immunology.
影响因子: --
作者: [Thorstenson,KristenM, Herzovi,Laura, Khoruts,Alexander]
通讯作者: Khoruts,Alexander
Regulatory CD4+CD25+Foxp3+ T cells selectively inhibit the spontaneous form of lymphopenia-induced proliferation of naive T cells.
调节性 CD4 CD25 Foxp3 T 细胞选择性抑制淋巴细胞减少诱导的初始 T 细胞的自发增殖。
DOI: 10.4049/jimmunol.180.11.7305
发表时间: 2008
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Winstead,ColleenJ, Fraser,JoanneM, Khoruts,Alexander]
通讯作者: Khoruts,Alexander
Identification of Intestinal Bacteria Protective against C. Difficile Colitis
  • 批准号:
    8206591
  • 项目类别:
  • 资助金额:
    $18.88万
  • 财政年份:
    2011
  • 负责人:
    ALEXANDER KHORUTS
  • 依托单位:
Identification of Intestinal Bacteria Protective against C. Difficile Colitis
  • 批准号:
    8023787
  • 项目类别:
  • 资助金额:
    $22.65万
  • 财政年份:
    2011
  • 负责人:
    ALEXANDER KHORUTS
  • 依托单位:
Translational control of regulatory T cell induction
  • 批准号:
    7914404
  • 项目类别:
  • 资助金额:
    $22.65万
  • 财政年份:
    2009
  • 负责人:
    ALEXANDER KHORUTS
  • 依托单位:
Translational control of regulatory T cell induction
  • 批准号:
    7701395
  • 项目类别:
  • 资助金额:
    $18.88万
  • 财政年份:
    2009
  • 负责人:
    ALEXANDER KHORUTS
  • 依托单位:
海外基金